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Abstract. 
 
Herbimycin A, a tyrosine kinase inhibitor, 
induces cellular differentiation and delayed apoptosis 
in Colo-205 cells, a poorly differentiated human colon 
carcinoma cell line. Cell cycle analysis in conjunction 
 
with end labeling of DNA fragments revealed that G
 
2
 
 
arrest preceded apoptotic cell death. Ultrastructural ex-
amination of herbimycin-treated cells demonstrated 
morphologic features of epithelial differentiation, in-
cluding formation of a microvillar apical membrane 
and lateral desmosome adhesions. A marked accumula-
tion of mitochondria was also observed. Fluorometric 
analysis using the mitochondrial probes nonyl-acridine 
orange and JC-1 confirmed a progressive increase in 
mitochondrial mass. However these cells also demon-
strated a progressive decline in unit mitochondrial 
 
transmembrane potential (
 
DC
 
m
 
) as determined by the 
 
DC
 
m
 
-sensitive fluorescent probes rhodamine 123 and 
JC-1 analyzed for red fluorescence. In concert with 
these mitochondrial changes, Colo-205 cells treated 
with herbimycin A produced increased levels of reac-
tive oxygen species as evidenced by oxidation of both 
dichlorodihydrofluorescein diacetate and dihydroethid-
ium. Cell-free assays for apoptosis using rat-liver nuclei 
and extracts of Colo-205 cells at 24 h showed that apop-
totic activity of Colo-205 lysates requires the early ac-
tion of mitochondria. Morphological and functional mi-
tochondrial changes were observed at early time points, 
preceding cleavage of poly (ADP-ribose) polymerase.
These results suggest that apoptosis in differentiated 
Colo-205 cells involves unrestrained mitochondrial pro-
liferation and progressive membrane dysfunction, a 
novel mechanism in apoptosis.
 
C
 
ells
 
 in hematopoietic and epithelial lineages main-
tain tissue homeostasis by a dynamic equilibrium
balancing cell proliferation and cell death (91).
Cell death in these lineages has been recognized as apop-
totic and generally occurs after a terminal differentiation
event (17, 126). These physiological cell deaths are re-
markably consistent in both timing and location. Mature
circulating neutrophils acquire apoptotic morphologies by
30 h after release from the bone marrow (28). Enterocytes
undergo apoptosis at villus tips in the small intestine and
at the colonic surface after terminal differentiation and
transit along the crypt–villus axis (32, 43, 90).
The control of apoptosis after terminal differentiation in
these systems is essentially unknown. Although down reg-
ulation of expression of bcl-2 and its homologues appears
to trigger other instances of physiological apoptosis (43,
66), the patterns of bcl-2 expression in these lineages with
rapid cell turnover do not explain the observed patterns of
cell death (93). Myeloid expression of bcl-2 is down regu-
lated in metamyelocytes and immature neutrophils (23).
Expression of bcl-2 within small and large intestinal epi-
thelia is confined to the lower 1/3 of the crypts (43). Thus,
down regulation of bcl-2 significantly precedes apoptotic
cell turnover as well as the completion of terminal differ-
entiation. The topographic distributions of the other bcl-2
family members reported to date also do not provide an
explanation for the coordinated apoptosis of terminally
differentiated cells (8, 55).
Cancer cells often have an immature phenotype repre-
senting a block in the normal differentiation pathway (6).
Treatments capable of inducing differentiation have been
discovered for cancer cell lines in vitro and have in some
cases been developed as anticancer therapies (6, 16, 112).
In the most successful application of this strategy, all-
 
trans
 
retinoic acid induces differentiation of acute promyelo-
cytic leukemias carrying the t(1;19) translocation (22, 26).
 
Please address all correspondence to Benjamin O. Anderson, Department
of Surgery, University of Washington, Box 356410, Seattle, WA 98195.
Tel.: (206) 543-6352; Fax: (206) 543-8136.
  
The Journal of Cell Biology, Volume 138, 1997 450
 
Complete remissions have been observed with this ther-
apy. Cells that have differentiated in this manner only re-
main viable for a few days, eventually undergoing apopto-
sis. Restoration of a normal differentiation program in
cancer cells thus appears to also activate an apoptotic
mechanism similar to the normal physiological process (83).
Herbimycin A, an antibiotic of actinomycetes origin be-
longing to the ansamycin group (84), is a natural tyrosine
kinase inhibitor that has been reported to induce differen-
tiation in several cell lines, including Rous sarcoma virus-
transformed rat kidney cells (76, 118, 119, 122), Rous sar-
coma virus-transformed chicken embryo fibroblasts (120),
and human K562 myelogenous leukemia cells (45). Re-
cently, we have observed herbimycin A to induce differen-
tiation of Colo-205, a human colon adenocarcinoma cell
line derived from malignant ascites, in association with in-
hibition of constitutive 
 
src
 
 and 
 
lck
 
 tyrosine kinase activi-
ties (Paty, P., and N. Rosen, unpublished observations). In
the same model, cell death by apoptosis follows differenti-
ation (Mancini, M., and B. Anderson, unpublished obser-
vation).
In the present study, we describe striking increases in
mitochondrial number within herbimycin-treated Colo-
205 cells. Unexpectedly, increased mitochondrial mass did
not lead to cellular accumulation of fluorescent probes
that reflect mitochondrial transmembrane potential (
 
DC
 
m
 
).
These results are consistent with impaired function of
newly synthesized mitochondria. Morphologic studies and
examination of cell-free assays indicate that progressive,
structural changes to mitochondria occur during prolifera-
tion and coincide with apoptotic activity in cell lysates.
 
Materials and Methods
 
Tissue Culture
 
The human colon adenocarcinoma cell line Colo-205 was used for all the
experiments (108). The cells were maintained in RPMI supplemented
with 10% fetal bovine serum (GIBCO BRL, Gaithersburg, MD), 100 U/ml
of penicillin, 100 ng/ml streptomycin, and 2 mM 
 
l
 
-glutamine, and grown in
75-cm
 
2
 
 tissue culture flasks at 37
 
8
 
C in a humidified 5% CO
 
2
 
 atmosphere.
They were refed every 48 h and passaged weekly.
 
Chemicals
 
Herbimycin A (GIBCO BRL) was dissolved in DMSO at a concentration
of 1 mg/ml, stored in 50-
 
m
 
l aliquots at 
 
2
 
20
 
8
 
C, protected from light, and
thawed immediately before use. 
 
N
 
-acetyl-
 
l
 
-cysteine (NAC; Sigma Chemi-
cal Co., St. Louis, MO) was dissolved in doubly distilled water (100 mM,
pH 7.4), stored in aliquots at 
 
2
 
20
 
8
 
C, and thawed immediately before use.
 
Drug Treatment of Colo-205 Cells
 
Experiments were carried out by subculturing Colo-205 cells at a density
of 1 
 
3
 
 10
 
5
 
 cells/ml in 10 ml medium/100-mm tissue culture plate. The cells
were grown for 24 h before drug treatment. Cells were treated with herbi-
mycin A (300 ng/ml) or vehicle (1% DMSO) and were refed with media
containing drug or vehicle at 48-h intervals. Cells were harvested at 0, 24,
48, or 96 h after treatment, collecting both adherent and nonadherent
cells. Adherent cells were collected either using 0.02% trypsin with 5 mM
EDTA or by gentle scraping with a rubber cell lifter. For the NAC experi-
ments, cells were treated with herbimycin or DMSO, and NAC was added
to the cells at time zero at a final concentration of 500 
 
m
 
M.
 
Transmission Electron Microscopy
 
Cells were harvested in PBS by gentle scraping and were pelleted by cen-
trifugation. The cell pellets were resuspended in half-strength Kar-
 
novsky’s fixative for 4–6 h, rinsed in 0.1 M cacodylate buffer, and post-
fixed in 1% collidine-buffered osmium tetroxide. Dehydration in graded
ethanol and propylene oxide was followed by infiltration and embedding
in Epon 812. Approximately 70–90-nm sections were stained using satu-
rated, aqueous uranyl acetate and lead tartrate. Photographs were taken
using a transmission electron microscope (100 SX; Jeol, Ltd., Tokyo, Ja-
pan) operating at 80 kV.
 
Detection of Apoptosis
 
In Situ Labeling of Free 3
 
9
 
-Hydroxyl Ends on DNA. 
 
Cells were harvested by
gentle scraping, washed in PBS, and counted. An aliquot of 100,000 cells
was resuspended in culture media and transferred to a microscope slide by
cytospin (800 rpm for 5 min). Cells were fixed in 4% buffered formalde-
hyde, and fragmented DNA was labeled using a modification of the
method of terminal deoxynucleotidyl transferase (TdT)
 
1
 
-mediated dUTP-
biotin nick end-labeling (TUNEL), described by Gavrieli et al. (32).
Briefly, nuclei of cell preparations were permeabilized by incubation with
80 
 
m
 
g/ml proteinase K for 10 min at room temperature. Endogenous per-
oxidases were inactivated by covering the sections with 2% H
 
2
 
O
 
2
 
 for 5
min at room temperature. After incubation for 5 min in TdT buffer (30
mM Tris, pH 7.2, 140 mM Na-cacodylate, 4 mM MgCl
 
2
 
, 0.1 mM DTT), the
slides were covered with TdT (0.3 U/
 
m
 
l) and biotinylated dUTP in TdT
buffer and incubated for 60 min at 37
 
8
 
C in a humidified chamber (TdT en-
zyme and dUTP obtained from Boehringer Mannheim, Indianapolis, IN).
Negative controls were incubated with biotinylated dUTP in TdT buffer
without enzyme. The reaction was terminated by transferring the slides to
TB buffer (300 mM NaCl, 30 mM Na citrate) for 15 min at room tempera-
ture. The sections were covered with 2% BSA for 10 min at room temper-
ature and immersed in PBS for 5 min followed by incubation with (1:1,000
dilution in PBS) HRP–streptavidin (Zymed Labs., Inc., S. San Francisco,
CA) for 30 min at 37
 
8
 
C. The sections were then covered with DAB cata-
lyzed with NiCl
 
2
 
 and H
 
2
 
O
 
2
 
 for 10 min and counterstained with 0.25%
methyl green in PBS. Positive controls were incubated for 10 min with
DNase (100 ng/ml, dissolved in DN buffer: 30 mM Tris-HCl, pH 7.2, 140
mM Na-cacodylate, 4 mM MgCl
 
2
 
, 0.1 mM DTT) before exposure to TdT.
After counterstaining, the apoptotic cells were quantified by counting a
minimum of 200 cells from at least 5 different random areas of the slide.
 
Diphenylamine (DPA) Assay for DNA Fragmentation (10). 
 
Cells were
detached from the plates by scraping and washed in PBS. 5 
 
3
 
 10
 
6
 
 cells
were resuspended in 500 
 
m
 
l of lysis buffer (5 mM Tris, pH 8, 20 mM
EDTA, 0.5% Triton X-100) for 15 min on ice. Lysed cells were then cen-
trifuged at 12,000 rpm in a microcentrifuge for 30 min at 4
 
8
 
C, and the su-
pernatant and pellet were separately analyzed by the DPA assay as previ-
ously described (42).
 
Western Blot Detection of Poly (ADP-ribose) Polymerase (PARP) Cleav-
age. 
 
Cells were harvested by trypsinization and centrifuged at 1,000 rpm
for 10 min. 1 
 
3
 
 10
 
5
 
 cells were heated for 15 min at 65
 
8
 
C in reducing load-
ing buffer (62.5 mM Tris-HCl, pH 6.8, 6 M urea, 10% glycerol, 2% SDS,
0.003% bromophenol blue, 6% freshly added 2-mercaptoethanol) and
loaded on a 6% SDS–polyacrylamide gel. Proteins were then electro-
transferred onto a nitrocellulose membrane and analyzed by immunoblot-
ting. The membrane was incubated with Blotto (5% nonfat dry milk, 0.1%
Tween 20 in PBS) for 1 h and then overnight with 1:10,000 dilution in
blocking buffer of anti-PARP monoclonal antibody (C2-10; Enzyme Bio-
Systems, Beloit, WI), followed by 30-min incubation with HRP-conju-
gated secondary anti–murine IgG (Jackson ImmunoResearch Laborato-
ries, West Grove, PA), diluted 1:2,500 in blotto. The signal was detected
using enhanced chemiluminescence (ECL; Amersham Intl., Buckingham-
shire, England).
 
Cell Cycle Analysis
 
Cell cycle analysis was performed by univariate flow cytometry using ei-
ther nuclei or whole cell preparations. For nuclei, asynchronously growing
cells were harvested without trypsinization in PBS supplemented with 1%
FCS, washed, and resuspended at a concentration of 1 
 
3
 
 10
 
6
 
 cells in 1.5 ml
of ice-cold PBS. After centrifugation, supernatants were discarded, and
the cell pellets were resuspended in 250 
 
m
 
l of Buffer A (10 mM Tris-HCl,
 
1. 
 
Abbreviations used in this paper
 
: 
 
DC
 
m
 
, mitochondrial membrane poten-
tial; DHE, dihydroethidium; H
 
2
 
-DCF-DA, dichlorodihydrofluorescein;
NAO, nonyl-acridine orange; PARP, poly (ADP-ribose) polymerase;
ROS, reactive oxygen species; TdT, terminal deoxynucleotidyl transferase. 
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pH 7.5, 20 mM NaCl, 20 mM MgCl
 
2
 
) and incubated on ice for 5 min. 250
 
m
 
l of Buffer B (Buffer A plus 1% NP-40) were then added to the cell sus-
pension for 5 min on ice. After adding 10 
 
m
 
g/ml of DNase-free RNase, nu-
clei were incubated at 37
 
8
 
C for 30 min. DNA staining was obtained with
500 
 
m
 
l of propidium iodide solution (PI; Molecular Probes, Eugene, OR)
in PBS (100 
 
m
 
g/ml PI, 0.1% Triton X-100, 1% FCS) for 1 h at 4
 
8
 
C in the
dark, followed by flow analysis. Whole viable cells were also used for cell
cycle analysis and stained with Hoechst 33342 (Sigma Chemical Co.).
Cells were incubated in culture with 0.5 
 
m
 
g/ml of Hoechst 33342 for 90
min at 37
 
8
 
C and then harvested by trypsinization and used for flow analy-
sis. To obtain better preservation of cytosolic DNA in apoptotic cells,
whole cells were analyzed after fixation with 1% paraformaldehyde (pH 7.4)
for 15 min on ice, followed by 70% ethanol. After being washed twice with
PBS, the cells were stained with PI according to the protocol described be-
low, and analyzed by flow cytometry. The DNA fluorescence was mea-
sured using a FACScan
 
®
 
 (Becton Dickinson, Bedford, MA) for PI or
FACS
 
®
 
 Vantage for Hoechst staining. Data acquisition was performed us-
ing the Cell Quest software (Becton Dickinson) and data analysis using
the Phoenix Flow System Multicycle AV software.
 
Assessing Relationship between Apoptosis and Cell Cycle. 
 
At each time
point, the cells were harvested by trypsinization, washed in PBS, and fixed
in 1% formaldehyde (pH 7.4) for 15 min on ice. At the end of the formal-
dehyde fixation the cells were washed twice in PBS, forcibly pipetted into
5 ml of 70% ethanol, and stored at 
 
2
 
20
 
8
 
C until ready for use. On the day
of the experiment, the cells were washed twice in PBS and resuspended in
50 
 
m
 
l of TdT reaction buffer containing 10 
 
m
 
l of 5
 
3
 
 concentrated buffer
solution (1 M sodium cacodylate, 125 mM Tris-HCl, pH 6.6, 1.16 mg/ml
BSA), 5 
 
m
 
l of 25 mM cobalt chloride, 12.5 U of TdT enzyme, 0.25 nmoles
of fluorescein-dUTP (TdT enzyme and fluorescein-dUTP were both ob-
tained from Boehringer Mannheim), and doubly distilled water up to 50
 
m
 
l (34, 64). The cells were incubated in this solution for 60 min at 37
 
8
 
C and
then rinsed twice with 1.5 ml of 15 mM EDTA, pH 8, and once with 1 ml
of 0.1% Triton X-100 in PBS. At the end of the washing, DNA counter-
staining was carried out by resuspending the cellular pellets in 1 ml of PI
solution in PBS (2.5 
 
m
 
g/ml PI, 10 
 
m
 
g/ml DNase-free RNase) and incubat-
ing them for 30 min at room temperature, shielded from light.
 
Assessment of Mitochondrial Changes
 
Relative mitochondrial mass was measured by flow cytometry using 10-
 
n
 
-
nonyl–acridine orange (NAO; Molecular Probes; 67, 88) or 5,5
 
9
 
,6,6
 
9
 
-tetra-
chloro-1,1,3,3
 
9
 
- tetraethylbenzimidazolcarbocyanine iodide (JC-1; Molec-
ular Probes; 94, 111), analyzed for green fluorescence. Mitochondrial func-
tion was indirectly assessed by variation in mitochondrial transmembrane
potential measured by rhodamine 123 (14, 49) and JC-1 red fluorescence.
ROS production was assessed by oxidation of 2
 
9
 
,7
 
9
 
-dichlorodihydrofluores-
cein diacetate (H
 
2
 
–DCF-DA; Molecular Probes) and dihydroethidium
(DHE; Molecular Probes) to fluorescent products 2
 
9
 
,7
 
9
 
-dichlorofluores-
cein (DCF) and ethidium (Eth), as measured by flow cytometry (5, 44, 99,
127).
 
NAO Staining. 
 
Cells were trypsinized, resuspended in 0.5 ml of PBS,
fixed in 70% ethanol, and stored until use at 
 
2
 
20
 
8
 
C. On the day of each
experiment, ethanol was removed by centrifugation, and 1 
 
3
 
 10
 
6
 
 cells
were washed in PBS and stained with 10 
 
m
 
M NAO in 1 ml of PBS. After
incubating for 10 min at room temperature in the dark, cells were washed
in PBS and submitted for flow analysis.
 
Rhodamine 123 Staining. 
 
Cells were trypsinized, resuspended in me-
dium at a concentration of 1 
 
3
 
 10
 
6
 
/ml, incubated for 30 min at 37
 
8
 
C with
0.5 
 
m
 
g/ml of rhodamine 123, and submitted immediately for flow analysis.
 
JC-1 Staining. 
 
1 
 
3
 
 10
 
6
 
 cells were resuspended after trypsinization in 1
ml of medium and incubated with 10 
 
m
 
g/ml of JC-1 for 10 min at 37
 
8
 
C be-
fore flow analysis. Both red and green fluorescence emissions were ana-
lyzed after JC-1 staining.
 
H
 
2
 
–DCF-DA and DHE Staining. 
 
Cells were incubated with 5 
 
m
 
M H
 
2
 
–
DCF-DA or DHE in tissue culture medium for 45 min at 37
 
8
 
C and then
washed, resuspended as 1 
 
3
 
 10
 
6
 
/ml in PBS, and submitted to flow analysis.
 
Flow Cytometric Analysis. 
 
A FACScan
 
®
 
 (Becton Dickinson, Bedford,
MA) was used for all the experiments. Forward and side scatters were
used to establish size gates and exclude cellular debris and apoptotic cells
from the analysis (13, 20). For each experiment both herbimycin- and
DMSO-treated cells were analyzed. The excitation wavelength was 488
nm. The observation wavelengths were 530 nm for green fluorescence and
585 nm for red fluorescence. Relative change in mean fluorescence was
calculated as the ratio of mean fluorescence channels for herbimycin to
DMSO-treated samples.
 
Cell-free Assay for Apoptosis
 
Cells were harvested by trypsinization at 0, 24, and 48 h after herbimycin
exposure. 5 
 
3
 
 10
 
6
 
 cells were rinsed in PBS, and the pellets were resus-
pended in 300 
 
m
 
l of lysis buffer (20 mM Hepes-KOH, pH 7.5, 10 mM KCl,
1.5 mM MgCl
 
2
 
, 1 mM sodium EDTA, 1 mM sodium EGTA, 1 mM DTT,
0.1 mM PMSF, supplemented with 2 
 
m
 
g/ml aprotinin, 5 
 
m
 
g/ml pepstatin A,
10 
 
m
 
g/ml leupeptin). The samples were left on ice for 15 min and then
lysed by 23 strokes with the B pestle in a Dounce homogenizer (Kontes
Glass Co., Vineland, NJ), and centrifuged at 1,000 
 
g
 
 for 10 min at 4
 
8C. The
resulting pellet (nuclear fraction) was discarded, and the supernatant (cyto-
solic fraction) was split in two parts and used for the in vitro apoptosis assay.
Protein content of the cell extract was determined by the Lowry method.
The lysates were adjusted to a fixed protein concentration (5 mg/ml). Half of
each lysate was further centrifuged at 10,000 g for 30 min at 48C. The result-
ing supernatant (S10 fraction) was collected. A preparation of rat liver nuclei
containing 200,000 nuclei/ml of buffer A (10 mM Pipes, pH 7.4, 80 mM KCl,
20 mM NaCl, 5 mM sodium EGTA, 250 mM sucrose, 1 mM DTT) was
kindly provided by Michael Wright (University of Washington, Seattle,
WA). The cell-free reactions were set up in Eppendorf tubes containing 1 ml
of nuclear preparation (200,000 nuclei) and 30 ml of Colo-205 lysate (whole
cytosolic fraction or S10 fraction), corresponding to 150 mg of protein. The
total volume was adjusted in each tube to 50 ml using dilution buffer (10
mM Hepes, 50 mM NaCl, 2 mM MgCl2, 5 mM EGTA, 1 mM DTT). The
samples were incubated for up to 2 h at 378C and then an aliquot of each re-
action (10 ml) was mixed 1:1 with staining solution (200 mM sucrose, 5 mM
MgCl2, 80 mM KCl, 15 mM NaCl, 5 mM EDTA, 150 mM Pipes-NaOH, pH
7.4, 10 mg/ml Hoechst 33258, 3.7% paraformaldehyde) and observed for nu-
clear morphological changes by fluorescence microscopy.
Statistics
Data are reported as mean 6SD except where indicated. Experiments
were performed in triplicate. Comparisons among multiple groups were
made by a one-way analysis of variance (ANOVA) followed by Fisher’s
protected least significant difference post-hoc test. 95% confidence limits
(P < 0.05) were considered significant.
Results
Herbimycin A Induces Growth Arrest Followed by Cell 
Death in Colo-205 Cells
Colo-205 cells treated with herbimycin A in a dose range
of 200–500 ng/ml demonstrate growth arrest, evident by 24 h
after treatment. A dose of 300 ng/ml produces maximal
growth arrest and differentiation, along with maximal inhi-
bition of src and lck tyrosine kinase activities in Colo-205
cells (Paty, P., and N. Rosen, unpublished observations).
Cell count, representing the net result of cell proliferation
and cell death, is decreased at 24 h in herbimycin-treated
cells compared to cells treated with DMSO alone (Fig. 1
a). Loss of cell viability, as measured by trypan blue exclu-
sion, is not apparent in herbimycin-treated cells until 48 h
(Fig. 1 b), suggesting that the early decrease in cell count
in herbimycin-treated cells results primarily from de-
creased proliferation rather than accelerated death. This
finding is confirmed by cell cycle analysis which shows that
herbimycin causes fewer cells to be in S phase at 24 h in
comparison to control, accompanied by accumulation of
the cells in G2/M at 24–48 h (see Fig. 6 and text below).
Both cell count and cell viability continue to decrease
throughout the 96-h observation period (Fig. 1, a and b).
Herbimycin A-induced Epithelial Differentiation Is 
Associated with Mitochondrial Proliferation
Colo-205 cells appear as small, round cells with scattered
spindle-shaped cells by light microscopy. These cells growThe Journal of Cell Biology, Volume 138, 1997 452
as semi-adherent cells in plastic tissue culture flasks. Addi-
tion of herbimycin A triggers a sequence of major mor-
phological changes in Colo-205 cells. At 24 h the cells are
adherent and appear larger, flattened, and less rounded.
They form aggregates and epithelioid colonies, which be-
come progressively larger from 24 to 96 h (Fig. 2).
Transmission electron microscopy demonstrates the ul-
trastructural characteristics of Colo-205 cells. Before her-
Figure 1. Growth and viability curves of Colo-205 cells treated with herbimycin A, 300 ng/ml (solid line), or DMSO vehicle, 1% (dotted
line). Cell growth, as expressed by number of viable cells/ml media (A) and cell viability, as measured by trypan blue exclusion (B), pro-
gressively decrease in cells treated with herbimycin A. Growth arrest starts 24 h before the decrease in viability becomes evident, sug-
gesting that herbimycin decreases cell proliferation and then induces cell death.
Figure 2. Phase contrast light microscopy images of Colo-205 cells during culture with herbimycin A (300 ng/ml). The small, round
Colo-205 cells visible at time 0 (a) show increase in size and tendency to form cellular aggregates at 24 h. At 48 h (c), the cells appear or-
ganized in epithelioid colonies, which appear larger at 96 h (d). Dead cells and cellular debris can be observed in culture at 48 and 96 h
of herbimycin exposure.Mancini et al. Mitochondrial Abnormalities and Apoptosis 453
bimycin exposure, they appear as isolated, small, rounded
cells, with a high nucleus-to-cytoplasm ratio and a simple
cytoplasmic organization with a paucity of organelles (Fig.
3 a). By 24 h after herbimycin treatment, Colo-205 cells
begin to acquire ultrastructural features of differentiation
(Fig. 3 b). They appear larger and form a rudimentary po-
larized monolayer with an emerging brush border. There
is a general increase in free ribosomes and rough endo-
plasmic reticulum. Some cells at 24 h were noted to have
increased numbers of mitochondria, many of which are
electron dense and have reduced volume as compared to
control cells (Fig. 3 b).
The differentiated phenotype of Colo-205 cells has pro-
gressed by 48 h of herbimycin treatment, when the cells as-
sume a more mature enterocytic morphology that resem-
bles that of the columnar absorptive lineage (77). In
particular, the cells acquire a polygonal shape, and cell po-
larity and the apical brush border are better defined, with
well-formed desmosomes connecting adjacent cells close
to their apical surface (Fig. 3 c). The number and conden-
sation of mitochondria appear further increased at this
time point.
At 96 h, surviving cells are found at the free surface of
larger cellular aggregates and appear highly differentiated
with long, narrow, and more numerous apical microvilli,
while underlying cells are apoptotic or appear to be under-
going secondary necrosis (see below). The superficial cells
of these clusters have condensed cytoplasm and decreased
intercellular contacts as compared to cells after 48 h of
treatment (Fig. 3 d). Zones of detachment between adja-
cent cells resemble those observed in terminally differenti-
ated enterocytes of normal colonic mucosa (90). Surpris-
ingly, after 96 h of herbimycin exposure, viable cells show
still higher numbers of highly condensed small mitochon-
dria, localized primarily to the apical side of cells (Fig. 3 d).
Apoptosis Follows Herbimycin-induced
Epithelial Differentiation
Between 48 and 96 h after herbimycin exposure, light mi-
croscopy showed a progressive reduction in cellular den-
sity, and both intact dead cells and cellular debris were vis-
ible (Fig. 2).
As the differentiation process continues, apoptotic fig-
ures become increasingly visible by electron microscopy.
While barely detectable at 24 h (8/400 cells), intact apop-
totic cells (Fig. 4 a) and apoptotic bodies (Fig. 4 b) are
readily apparent from 48 to 96 h. Apoptotic cells demon-
strate intact cell membranes with cytoplasmic and chroma-
tin condensation (Fig. 4 a). Apoptotic bodies contained ei-
ther highly condensed chromatin typical of apoptosis or
finely dispersed chromatin, resembling a chromatolytic
morphology. These latter changes were consistent with
post-apoptotic or secondary necrosis (68).
The presence of delayed apoptosis was confirmed by
other assays. Tunel, a specific, histologic method for detec-
tion of nuclear DNA fragmentation (32), identified 15%
of nuclei as apoptotic 48 h after herbimycin addition to the
cells (Fig. 4 c). The DPA assay, a quantitative measure of
soluble DNA released from apoptotic nuclei into the cyto-
plasm (10), demonstrated DNA fragmentation at 48 and
96 h (Table I). Similarly, DNA histograms of PI-stained
Colo-205 nuclei showed a progressive increase in events
with sub-diploid DNA content (the “sub-G1 peak”) which
is characteristic of apoptosis (82). The frequency of sub-G1
events was 0, 3, 15, and 42% at 0, 24, 48, and 96 h, respec-
tively (Fig. 5).
These results permit us to identify a sequence of herbi-
mycin-induced events in Colo-205 cells. Growth arrest and
differentiation are observed by 24 h. At 48 h, cellular via-
bility begins to decrease, and apoptosis, quantified by
Tunel, DPA, and frequency of sub-G1 events, is detect-
able. At 96 h the general viability is further reduced and
apoptosis increased. Thus, growth arrest, differentiation,
and apoptosis proceed sequentially in this model. Mito-
chondrial number increases progressively at each stage,
starting at 24 h. During the program of terminal differenti-
ation of normal colonic mucosa, cell cycle arrest in G1 pre-
cedes differentiation and apoptosis (27). To determine the
effect of herbimycin on cell cycle progression, cell cycle
analysis of Colo-205 cells was performed.
Cell Cycle Events: G2/M Accumulation and Its 
Relationship to Herbimycin-induced Apoptosis
Cell cycle distribution in Colo-205 cells after exposure to
herbimycin was assessed by flow cytometric measurement
of cellular DNA content. Analysis was carried out first on
isolated nuclei stained with PI. In this case cell cycle analy-
sis showed reduction of S phase at 24 h and subsequently,
appearance of a progressively larger sub-G1 population
(sub-G1 peak), indicative of apoptosis (Fig. 6, top row).
A different result was obtained when flow analysis was
performed on whole cells, either viable and stained with
Hoechst 33342 or fixed (1% paraformaldehyde and 70%
ethanol) and stained with PI (18). A better preservation of
the degraded, low molecular weight DNA inside the apop-
totic cells can be achieved in this way (20, 21). Cell cycle
analysis of whole cells showed early reduction of S phase
at 24 h, as already seen by analyzing nuclei. At 24–48 h,
however, an accumulation of cells in G2/M is evident (Fig.
6, middle and bottom rows). Careful analysis of the raw
data showed a wide shoulder of events at the left of the G2/M
peak at 48 h, suggesting a concealed sub-G2 peak (Fig. 6,
middle and bottom rows). Indeed, a population of cells
with a DNA content below the normal G2/M content can
be detected. Because of its shape and also the observed
early decrease in S phase, this peak is most likely due to
DNA fragmentation of the G2 cells and could be defined
as a “sub-G2 peak”. A sub-G2 peak is not evident when the
analysis is performed on nuclei (Fig. 6, top row), where a
larger sub-G1 peak predominates. This is probably due to
extraction and loss of low molecular weight DNA frag-
ments during the preparation of nuclei from the apoptotic
cells in G2 (1, 20). Consistent with this hypothesis, nuclei
preparations do not show an increased G2/M peak.
Fixation of whole cells with paraformaldehyde allowed
a better preservation of the sub-G2 peak (Fig. 6, bottom
row). Conforming with the previously shown increase in
apoptosis at 96 h, the sub-G2 peak is increased at this time
point. The G2 peak is decreased, also suggesting that apop-
tosis is depleting G2 cells. The widened G1 peak present in
fixed cells at 96 h (Fig. 6, bottom row) probably represents
sub-G1 and G1 populations similar to the one representedThe Journal of Cell Biology, Volume 138, 1997 454
Figure 3. Transmission electron microscopy images of Colo-205 cells illustrating the differentiation process induced by in vitro exposure
to herbimycin A (300 ng/ml). Untreated cells appear undifferentiated (a). By 24 h after herbimycin treatment (b), the cells tend to form
a polarized monolayer with an emerging brush border (arrows). Some cells at this time point show increased numbers of small electron-Mancini et al. Mitochondrial Abnormalities and Apoptosis 455
dense mitochondria (arrowheads). By 48 h, cells develop a more differentiated, polarized phenotype (c) with well formed desmosomes
connecting adjacent cells (arrows). Some mitochondria show signs of degeneration and derangement of the membranes (arrowheads). At
96 h (d), adjacent differentiated cells show many highly condensed, small mitochondria and zones of intercellular detachment (asterisks).The Journal of Cell Biology, Volume 138, 1997 456
in Fig. 6, middle row. Due to software limitations, it is not
possible to discriminate sub-G1 together with sub-G2 pop-
ulations in this sample.
Simultaneous measurement of DNA content (cell cycle)
and apoptotic strand breaks (DNA fluorescein-dUTP la-
beling) was also performed (34, 64). While absent at 0 and
24 h, TdT labeling is confined to the population of cells in
G2 and sub-G2 at 48 h (Fig. 7). This result confirms that ap-
optosis begins in Colo-205 cells residing in G2 after herbi-
mycin treatment. By 96 h, the extensive DNA degradation
may not be detectable in G2 cells by the TdT assay of
Figure 4. Electron and light microscopic images illustrating her-
bimycin-treated Colo-205 cells undergoing apoptosis. A whole
apoptotic cell (a) has a mostly intact cellular membrane with cy-
toplasmic shrinkage and condensation. The nucleus appears pyk-
notic and fragmented (arrows). The cell also seems to be under-
going fragmentation (arrowheads), forming an apoptotic body.
Apoptotic bodies at various stages of degeneration (b); some
contain highly condensed chromatin (arrowhead), and others ap-
pear to be nuclear fragments undergoing chromatolysis (arrow),
as in post-apoptotic necrosis. Tunel staining of Colo-205 cells at 48 h
after herbimycin treatment labels apoptotic nuclei in black (c).
Table I. Percentage Cytosolic DNA (Dpa Assay)
0 h 24 h 48 h 96 h
DMSO (vehicle) 1 6 14  6  31  6  11  6  1
Herbimycin A 1 6 15  6  1 23  6 5* 35 6 4*
DMSO (vehicle) 1 NAC 2 6 12  6  12  6  11  6  1
Herbimycin A 1 NAC 2 6 13  6  12   6  13  6  1
*P , 0.01 vs 0 h and DMSO (all groups)
DNA strand break labeling because very excessively frag-
mented, small molecular weight DNA cannot be retained
in the cells and is extracted during the sample preparation
(Darzynkiewicz, Z., personal communication).
Cell cycle analysis, in conclusion, shows an early de-
crease in S phase, with G2 accumulation at 24–48 h and ev-
idence of apoptosis beginning in G2 at 48 h.
Herbimycin A Induces Increased
Mitochondrial Mass but Decreased Relative 
Mitochondrial Transmembrane Potential
The mitochondrial abnormalities observed by electron mi-
croscopy during herbimycin-induced differentiation were
further evaluated using specific fluorescent mitochondrial
probes. To measure changes in mitochondrial mass, cells
were stained at different time points with NAO (67), a flu-
orescent dye that specifically binds to the mitochondrial
inner membrane independent of energetic state (DCm).
Herbimycin-treated cells showed a progressive increase in
mean NAO fluorescence with time (Table II), consistent
with the increased number of mitochondria per cell ob-
served on electron microscopy. In contrast, rhodamine 123
fluorescence, an indicator of DCm (14, 49), did not increase
after herbimycin treatment. Thus, the cellular mitochon-
drial transmembrane potential per unit mitochondrial
mass, expressed as the ratio of rhodamine 123 to NAO flu-
orescence, decreased throughout the 96-h experimental
period (Table II).
To control for potential differences in NAO/rhodamine
123 loading, we repeated the mitochondrial staining exper-
iments using the J-aggregate forming lipophilic cation JC-1
(Fig. 8, a and b). This mitochondrial dye, which normally
exists in solution as a monomer emitting a green fluores-
cence, assumes a dimeric configuration emitting red fluo-
rescence in a reaction driven by mitochondrial transmem-
brane potential (94, 111). Thus, the use of JC-1 allows
simultaneous analysis of mitochondrial mass (green fluo-
rescence) and mitochondrial transmembrane potential
(red fluorescence). After treatment with herbimycin we
again observed a progressive dissociation between mito-
Figure 5. The frequency of sub-G1 events (percentage of parti-
cles in the “sub-G1 peak”) obtained analyzing nuclear prepara-
tions from Colo-205 cells after 0, 24, 48, or 96 h of treatment with
herbimycin A (300 ng/ml) or DMSO vehicle (1%). The increas-
ing number of events with sub-G1 DNA content in herbimycin-
treated samples is characteristic of apoptosis.Mancini et al. Mitochondrial Abnormalities and Apoptosis 457
chondrial mass and DCm, with incremental increases in JC-1
green fluorescence without a corresponding increase in
JC-1 red fluorescence. Like the rhodamine 123 to NAO ratio,
the JC-1 red to green fluorescence ratio decreased with
time as differentiation and apoptosis progressed (Table II).
The consistent results of the mitochondrial staining ex-
periments, while confirming the increase in mitochondrial
mass observed by electron microscopy, showed a decrease
in unit mitochondrial transmembrane potential. This pat-
tern has been associated with mitochondrial uncoupling
and increased mitochondrial production of ROS (127). We
subsequently tested whether ROS production increased in
this model.
Herbimycin A Induces Increased ROS Generation
We tested the production of ROS by staining with DHE
and H2–DCF-DA, which are oxidized in the presence of
superoxide (O2
2) and peroxides, respectively, to fluores-
cent products (5, 44, 99, 127). Production of O2
2 and per-
oxides in herbimycin-treated Colo-205 cells increased with
time (Fig. 9, and Table II). At 24 h, before detection of ap-
optosis, an increase in ROS production was already appar-
ent, corresponding to the first decrease in the ratio of JC-1
red and green fluorescence. This correlation was main-
tained at later times, as the population continued to show
an increase in ROS production and a proportional de-
crease in JC-1 red to green ratio (Fig. 9, and Table II).
Figure 6. Cell cycle analysis
of Colo-205 cells after 0, 24,
48, and 96 h of incubation
with herbimycin A, as as-
sessed by analysis of DNA
content and represented in
histograms plotting DNA
content versus cell number.
Nuclear preparations stained
with propidium iodide were
analyzed first (top row). The
histograms show an early de-
crease in S phase and a pro-
gressively larger sub-G1 peak,
characteristic of apoptosis.
Analysis of viable whole cells
stained with Hoechst 33342
(middle row) revealed a G2/
M accumulation starting at
24 h of treatment and peak-
ing at 48 h. At this time point,
a sub-G2 peak is detected by
the computer software, sug-
gesting beginning apoptosis
in G2/M. Fixation of whole
cells with 1% paraformalde-
hyde, followed by propidium
iodide staining, shows a bet-
ter preservation of the sub-
G2 peak at 48 and 96 h (bot-
tom row).
Figure 7. TdT flow cytometry of Colo-205 cells after 0, 24, 48, and 96 h of incubation with herbimycin A. The graphs plot DNA content
on the x-axis and TdT-labeled apoptotic DNA strand breaks on the y-axis. No increase in TdT labeling above baseline is apparent at 24 h
after addition of herbimycin. By 48 h, a population of cells with increased TdT-labeling is present, corresponding to the cells with DNA
content in the sub-G2 and G2/M phase of the cell cycle. By 96 h, extensive DNA loss due to massive cell death is represented as a shift to
the left on the DNA histogram, preventing significant TdT labeling at this time point.The Journal of Cell Biology, Volume 138, 1997 458
Table II. Mean Fluorescence Values of Mitochondrial Mass, 
DCm, and ROS Production in Herbimycin-treated Cells 
(Relative to DMSO Control Cells)
0 h 24 h 48 h 96 h
NAO 1 1.5 6 0.3* 1.6 6 0.3* 1.8 6 0.5*
Rhodamine 1 1.1 6 0.1 1.1 6 0.3 0.7 6 0.2
Rhodamine/NAO 1 0.7 6 0.3 0.6 6 0.2* 0.4 6 0.2*
JC-1 green 1 1.5 6 0.1* 1.7 6 0.1* 3.0 6 0.3*
JC-1 red 1 1.0 6 0.1 1.0 6 0.3 1.0 6 0.2
Red/green 1 0.7 6 0.1* 0.6 6 0.2* 0.3 6 0.1*
O2
2 (DHE) 1 1.3 6 0.1 1.6 6 0.3* 1.8 6 0.4*
H2O2 (DCFH) 1 2.5 6 0.6 3.0 6 1.1* 4.0 6 1.7*
*P < 0.05 vs 0 h.
Figure 8. JC-1 fluorescence in Colo-205 cells after 24 and 48 h of
incubation with herbimycin A or DMSO vehicle. JC-1 green fluo-
rescence (mitochondrial mass) increases with time while JC-1 red
fluorescence (DCm) remains relatively unchanged. These findings
suggest that herbimycin induces proliferation of mitochondria
with decreased net transmembrane potential per unit mitochon-
drial mass.
Figure 9. H2–DCF-DA ® DCF and DHE ® Eth fluorescence in
Colo-205 cells after 48 and 96 h of incubation with herbimycin A.
Herbimycin-treated cells demonstrate progressively increasing
ROS production as compared with the DMSO controls. Peak
ROS production is concomitant with maximal induction of apop-
tosis at 96 h.
Sequence of Ultrastructural Changes in Mitochondria 
during Herbimycin Exposure
Sequential changes in mitochondrial ultrastructure were
identified in differentiating Colo-205 cells by electron mi-
croscopy. On the electron micrographs, the extent of nu-
clear chromatin condensation can be correlated with
changes in mitochondrial number and structure within the
same cell. Before addition of herbimycin, the mitochon-
dria appear oval shaped, with a finely granular matrix con-
taining a few dense granules (Fig. 10 a). The cristae are
sparse, and the mitochondria are occasionally adjacent to
endoplasmic reticulum cisternae.
24 h after addition of herbimycin, the increase in mito-
chondrial number is associated with more elongated
forms. The matrix is condensed, and the cristae are well
formed, often traversing the mitochondrion. Wide cister-
nae of rough endoplasmic reticulum are wrapped around
mitochondria, and a general increase in the number of
polysomes in the cytoplasm is observed (Fig. 10 b). This
feature suggests an increase in protein synthesis and mito-
chondrial import during the early stages of herbimycin-
induced apoptosis. Lysosome-like vacuoles containing
myelin figures are sometimes seen juxtaposed to mitochon-
dria/rough endoplasmic reticulum complexes and may repre-
sent ongoing autophagocytosis of damaged organelles (33).
Nuclear chromatin in the cells appears normal at this stage.
As differentiation proceeds through 48 h, the mitochon-
dria become more numerous, small and condensed, while
the associations with rough endoplasmic reticulum cister-
nae progressively decrease (not shown). Deranged cristae
suggest the development of mitochondrial degeneration
(Fig. 3 c). Overall these changes are suggestive of exten-
sive mitochondrial proliferation, coupled with matrix con-
densation and volume loss.
Mitochondrial ultrastructure in differentiated cells at 96 h
is characterized by hypercondensation of the matrix and
further reduction in size, with high numbers of mitochon-
dria packed in the cytoplasm (Fig. 11 a). The outer mito-Mancini et al. Mitochondrial Abnormalities and Apoptosis 459
Figure 10. High magnification electron microscopy images of Colo-205 cells before (a) and after (b) 24 h of herbimycin treatment.
Change in mitochondrial morphology is characterized by condensation of the matrix and markedly increased association with wide cis-
ternae of rough endoplasmic reticulum. Lysosome-like vacuoles adjacent to mitochondria (arrow) suggest ongoing autophagocytosis.The Journal of Cell Biology, Volume 138, 1997 460
Figure 11. High and low magnification electron microscopy images of Colo-205 cells after 96 h of herbimycin treatment. Mitochondria
appear increased in numbers, hypercondensed, and small. The association between mitochondria and the cisternae of rough endoplas-
mic reticulum is decreased (a). At lower magnification this mitochondrial morphology is observed in apical differentiated cells (b) de-Mancini et al. Mitochondrial Abnormalities and Apoptosis 461
taching from the neighboring cells (asterisks). Subsequent mitochondrial degeneration is characterized by intracristal ballooning (c) fol-
lowed by mitochondrial swelling (d) with interruption of the mitochondrial membrane (arrowhead) and profiles suggestive of
mitochondrial division (arrows).The Journal of Cell Biology, Volume 138, 1997 462
chondrial membrane appears indistinct, and internal struc-
tures are obscured by the highly electron-dense matrix.
The close association between mitochondria and rough
endoplasmic reticulum is no longer seen. The nuclear
chromatin at this stage is condensed and marginated.
Finally, a spectrum of degenerative changes is noted in
the mitochondria of cells in advanced apoptosis 96 h after
treatment with herbimycin. This pattern is characterized
by mitochondrial swelling and loss of matrix density. The
nuclear chromatin and the cytoplasm are also less con-
densed, and many cells have a morphological appearance
characteristic of post-apoptotic necrosis (Fig. 11 b). As the
nuclear chromatin appear less condensed, the mitochon-
dria show enlargement of the cristae (intracristal swelling
or ballooning). The matrix appears still condensed, but to
a lesser degree than before, while the total mitochondrial
volume does not appear increased (Fig. 11 c). Chromatoly-
sis is associated with a more advanced mitochondrial pa-
thology (Fig. 11 b). Widening of the intracristal space be-
comes more evident, and the mitochondria show a high
degree of swelling and appear electron lucent and more
rounded (Fig. 11 d). The matrix contains flocculent densi-
ties, and the outer membrane is often discontinuous. The
internal mitochondrial structure becomes visible again and
shows some cristae dividing the organelle into two sym-
metric halves (partition), a feature suggestive of mitochon-
drial division (33).
NAC Prevents Herbimycin-induced Mitochondrial 
Changes and Protects the Cells from Apoptosis
We subsequently tested the effect of NAC on Colo-205
cells exposed to herbimycin. NAC has been previously
shown to protect cells against damage associated with oxi-
dative stress (3, 73, 74, 113). Colo-205 cells treated with a
combination of 500 mM NAC and herbimycin A did not
undergo apoptosis (Table I). Herbimycin-induced epithe-
lial differentiation was not affected by NAC, as judged by
light and electron microscopic inspection. However, mito-
chondrial proliferation in response to herbimycin was
abolished by co-treatment with NAC. JC-1 green fluores-
cence and the ratio of red to green fluorescence intensities
remained at baseline values under these conditions (Table
III). The absence of mitochondrial changes was confirmed
by EM, demonstrating a lack of change in mitochondrial
number and morphology, despite the development of a
characteristic differentiated cellular phenotype (not shown).
Mitochondria-enriched Fractions Are Required for 
Apoptotic Activity of Colo-205 Lysates
As a further indicator of the relationship of mitochondrial
changes to the apoptotic program, we tested whether apop-
totic “activity” in cell-free assays showed an early depen-
dence on mitochondria from Colo-205 cells. Using rat liver
nuclei to score apoptotic responses, cytosolic extracts were
prepared from Colo-205 cells exposed to herbimycin for 0,
24, and 48 h. Extracts were incubated with the nuclei for 1 h
at 378C. Extracts of Colo-205 cells at time 0 did not show
apoptotic activity (Fig. 12 a). In contrast, cytosolic extracts
of cells treated with the drug for 24 h induced classical
changes of apoptosis in the target nuclei after 1-h incuba-
tion at 378C (Fig. 12 b). We removed a heavy membrane
fraction containing mitochondria from cell lysates, by cen-
trifugation at 10,000 g for 30 min. The S10 supernatant at
24 h had no demonstrable apoptotic activity in the cell-
free assay even after 2 h of incubation with nuclei (Fig. 12
c). 48-h extracts showed similar apoptotic activity to the
24-h samples, but the corresponding S10 supernatant was
still able to induce partial apoptotic responses in the target
nuclei (not shown). These results indicate that at 24 h, be-
fore irreversible activation of cytoplasmic components, the
apoptotic program induced by herbimycin requires the
early action of mitochondria.
Table III. Mean Fluorescence Values of Mitochondrial Mass 
and DCm in Herbimycin 1 NAC-treated Cells (Relative to 
DMSO 1 NAC Control Cells)
0 h 24 h 48 h 96 h
JC-1 green 1.0 1.0 6 0.1 1.0 6 0.1 1.3 6 0.7
JC-1 red 1.0 1.2 6 0.1 0.9 6 0.3 1.1 6 0.5
Red/green 1.0 1.2 6 0.2 0.9 6 0.3 0.8 6 0.1
P 5 NS.
Figure 12. Cell free assay for apoptosis incubating rat liver nuclei with cytosolic extracts from Colo-205 cells. Colo-205 extracts (protein
concentration 5 mg/ml) were incubated with rat liver nuclei for 1 h (378C) and then visualized by fluorescence microscopy after DNA
staining (Hoechst 33258). (A) Nuclei exposed to cytosolic extract of untreated Colo-205 cells appear normal. (B) Nuclei exposed to cy-
tosolic extract of Colo-205 cells treated with herbimycin for 24 h show chromatin margination and condensation. (C) Nuclei exposed to
S10 fraction from Colo-205 cells treated with herbimycin for 24 h show normal morphology.Mancini et al. Mitochondrial Abnormalities and Apoptosis 463
Figure 13. Western blot detec-
tion of PARP in Colo-205 cells
at time 0 and after treatment
with herbimycin A or vehicle
for 24, 48, and 96 h. Cleavage
of PARP (116 kD) yields the
85-kD fragment detectable at
48 and 96 h of herbimycin ex-
posure. PARP cleavage is not
detected in untreated cells
(time 0) or the DMSO-treated
control cells. The faint 85-kD
band seen in the herbimycin
cells 24 h after treatment is a
result of increased protein
loading in this lane and was
not observed in two other runs
of the same experiment.
Herbimycin-induced Mitochondrial Changes Precede 
PARP Cleavage
To assess the activation of ICE family members in Colo-
205 cells, we examined cleavage of PARP, a proteolytic
target of the CPP32/Yama protease (81, 115). Cleavage of
PARP to an 85-kD fragment has been described as an
early event in drug-induced apoptosis in mammalian cells
(51). The 85-kD proteolytic fragment of PARP was first
detected in immunoblots of Colo-205 lysates after 48 h of
exposure to herbimycin A (Fig. 13). Changes in mitochon-
drial morphology, as well as an increase in mitochondrial
numbers and a decrease in the JC-1 red/green ratio have
already occurred by 24 h (Figs. 8 and 10 b, and Table II),
preceding PARP cleavage.
Discussion
The nonspecific tyrosine kinase inhibitor herbimycin A
can induce differentiation in several experimental models
(45, 120). Experimentally transformed cell lines treated
with herbimycin can also transiently revert to an untrans-
formed phenotype (76, 118, 120, 121). We have been
studying herbimycin-induced epithelial differentiation in
the human colon cancer cell line Colo-205, associated with
inhibition of src and lck tyrosine kinase activities (Paty, P.,
and N. Rosen, unpublished observations).
In the present study we report that, in addition to differ-
entiation, herbimycin induces apoptotic cell death in Colo-
205 cells. Moreover, the two events occur sequentially.
Differentiation starts 24 h after herbimycin exposure and
appears fully developed at 48 h, while apoptosis becomes
detectable at 48 h and peaks at 96 h. This relationship be-
tween differentiation and apoptosis in Colo-205 cells ap-
pears to mirror the changes occurring in normal colonic
mucosa during the physiologic program of terminal differ-
entiation of enterocytes (15, 77). The undifferentiated stem
cells localized at the base of colonic crypts give rise to
daughter cells that differentiate and migrate up the crypt
to reach the mucosal surface, where they die by apoptosis
and are sloughed from the colonic surface (32, 90). The
physiologic life span of the differentiating cells lasts about
3–5 d (15). Terminal differentiation in the immortalized
undifferentiated cell line Colo-205 after in vitro exposure
to herbimycin is also followed by apoptosis after a similar
time lag, suggesting that the enterocyte pathway of termi-
nal differentiation and apoptosis are tightly linked. In our
model, we also observe that a small number of cells undergo
apoptosis as early as 24 h. This is consistent with findings
in normal intestine where scattered apoptotic cells are de-
tected at multiple levels of the crypt–villus axis, including
occasional cells adjacent to the crypt bases (90, 107).
Herbimycin A also induces an accumulation of Colo-205
cells in the G2/M phase of the cell cycle. Apoptosis seems
to occur preferentially in G2/M, as demonstrated by the
presence of a sub-G2 apoptotic peak and of positive TdT
labeling of G2/M cells (20, 34). Another tyrosine kinase in-
hibitor, genistein, has been shown to induce G2 arrest in
vitro (72). We have also observed that genistein induces in
Colo-205 cells G2 arrest, differentiation, and apoptosis, sim-
ilar to herbimycin (Mancini, M., and B. Anderson, unpub-
lished observations). Roche et al. showed that signal trans-
duction pathways involving tyrosine kinases function in
mitosis, in particular, src family kinases are required for the
G2–M transition (98). As a consequence, one of the direct
effects of herbimycin could be to arrest the cells in the G2
phase of the cell cycle.
Terminal differentiation normally occurs when the cells
exit the cell cycle and arrest in G1 (27). However, a G1 ar-
rest may not be necessary for commitment to terminal dif-
ferentiation. A number of drugs known to cause a cell cy-
cle delay in G2 are able to induce terminal differentiation
in murine Friend erythroleukemia (FEL) and K562 leuke-
mia cells (24, 130).
Besides typical apoptotic cells and apoptotic bodies, we
also observed in our EM preparations, particularly at 96 h,
some cells with a phenotype characteristic of cellular ne-
crosis, i.e., chromatolysis, cytoplasmic vacuolization, and
disruption of the cellular membrane. We interpret this cel-
lular morphology as a secondary event to apoptosis, or “post-
apoptotic necrosis,” as recently proposed by Majno and
Joris (68). The appearance of a necrotic morphology after
apoptosis has been described in embryonic tissues and in
dermatopathology (103, 125). Even in the classical model
of apoptosis induction described by Kerr, the ligation of
the main portal venous trunk to the left and median lobes
of the rat liver with consequent liver atrophy and forma-
tion of Councilman bodies, these are found to sometimesThe Journal of Cell Biology, Volume 138, 1997 464
undergo severe degenerative changes resembling necrosis
(52, 53). A possible apoptosis–necrosis sequence has also
been recently reported in dystrophin-deficient muscle
cells, previously believed to die primarily by necrosis
(116). It is not known whether post-apoptotic necrosis oc-
curs during the late stages of terminal differentiation of
normal enterocytes. Phagocytosed apoptotic bodies in var-
ious stages of lysosomal digestion have been observed in
the stratified colonic mucosa of rat embryos (38), but in a
study by Potten and Allen on adult mouse small intestinal
mucosa, phagocytosis and cellular fragmentation were
seen only in cells dying at lower positions along the crypt–
villus axis, with a less differentiated phenotype (90). Ter-
minally differentiated cells were shown to be shed at the
villus tip after loss of contact with the neighboring cells,
without undergoing phagocytosis. Early apoptotic changes,
such as nuclear pyknosis and chromatin margination were
observed in terminally differentiated enterocytes, but they
were mostly extruded as whole cells (90). It is possible that
later, once in the bowel lumen, they undergo further de-
generation in the form of post-apoptotic necrosis.
Our results show that herbimycin-induced differentia-
tion in Colo-205 cells is associated with an increase in mi-
tochondrial number but without a concomitant increase in
net mitochondrial transmembrane potential. These results
suggest an accumulation of mitochondria with low trans-
membrane potential. There is scant information available
on the role of mitochondria during terminal differentia-
tion programs. Studies by Heerdt and colleagues have re-
ported increased mitochondrial gene expression in colon
carcinoma cells after induction of differentiation along the
absorptive lineage (39) and that increased mitochondrial
gene expression is a consistent and early event during apop-
tosis of colonic carcinoma cells in vitro (40). The impor-
tance of mitochondrial abnormalities during apoptosis has
been gaining support recently (41), despite the classical
descriptions of apoptosis with morphological preservation
of mitochondria (53). The availability of fluorescent dyes
which specifically reflect mitochondrial mass and function
has enabled more detailed studies of mitochondrial modi-
fications during apoptosis (87). Vayssiere et al. have
shown in rat embryo fibroblasts transfected with a temper-
ature-sensitive mutant of SV40 T antigen that reduction of
DCm is an early event during apoptosis triggered by inacti-
vation of SV40 T antigen (123). Petit et al. have reported
similar results in dexamethasone-induced apoptosis of mu-
rine thymocytes (89). Apoptosis in peripheral lymphocytes
from mice treated with dexamethasone is correlated with
an early reduction in DCm, while classical nuclear features
of apoptosis are not detectable in vivo (127).
The increase in mitochondrial number during herbimy-
cin-induced differentiation in Colo-205 cells is associated
with condensation of the mitochondrial matrix and a re-
duction in total mitochondrial volume. This condensed ap-
pearance is notable at early time points in Colo-205 cells,
before apoptotic changes in the nucleus. The degree of mi-
tochondrial condensation subsequently increases in con-
cert with the appearance of chromatin and cytoplasmic
condensation. At later time points, signs of mitochondrial
degeneration are apparent, characterized initially by dila-
tation of the intracristal space and then by progressive
swelling of the mitochondria, with interruption of the
outer membrane and loss of matrix density. This sequence
of mitochondrial modifications in Colo-205 cells after her-
bimycin treatment, represented in Figs. 10 and 11, shows a
transition from an orthodox, to condensed, to transitional,
and finally to swollen conformation (33). Transitional and
swollen morphologies are associated with progressive chro-
matolysis and necrotic degeneration of the cells. 
Morphological studies by Hackenbrock and colleagues
have shown that a reversible transition of mitochondrial
morphology from an orthodox to a condensed conforma-
tion is associated with high and low energy states of mito-
chondria, respectively (35–37). The condensed morphol-
ogy is characterized by a reduction in the inner mitochondrial
compartment due to increased folding of the inner mem-
brane, with a consequent increase of the outer compart-
ment, intracristal space and without significant reduction
of the total mitochondrial volume. Further studies on mi-
tochondrial morphology in response to inhibition of ATP
synthesis or cellular injury published by Laiho and col-
leagues demonstrated a sequence of mitochondrial modifi-
cations from the orthodox, to condensed, and eventually
to swollen mitochondrial conformations (60, 61). A transi-
tional morphology characterized by increased intracristal
space can also be observed between the condensed and
the swollen configuration. In these studies the condensed
conformation, due to loss of water and ions from the mito-
chondrial inner compartment, was associated with de-
creased ATP synthesis, with or without decreased respira-
tion, while the swollen conformation represents a more
advanced stage of damage to the inner mitochondrial
membrane and is usually associated with cellular necrosis.
The condensed conformation was reversible before the
“point of no return” is reached. Nevertheless the con-
densed conformation is unstable, and, in situations of con-
tinued injury, the mitochondrial membrane becomes
permeable and the organelle swells progressively, with
rupture of the outer membrane and destruction of the dif-
ferent components (60, 61). The appearance of a mito-
chondrial condensed morphology, followed by progressive
mitochondrial swelling, has also been recently reported by
Papadimitriou et al. to occur during complement-medi-
ated cell death in Ehrlich ascites tumor cells (85).
The sequence of mitochondrial alterations observed in
herbimycin-treated Colo-205 cells differs in some respects
from that observed by Laiho and Trump (60). At a time
when the degree of mitochondria condensation in Colo-
205 cells is advanced, the outer and inner mitochondrial
membranes appear closely associated, the intracristal space
is not enlarged, and the total mitochondrial volume is re-
duced. This morphology could be described as “mitochon-
drial pyknosis,” characterized by hyperdensity of the matrix
and reduction in mitochondrial size (33). It is possible that
in our model the pyknotic configuration represents a more
extensive and pathological degree of mitochondrial con-
densation, with contraction of the outer mitochondrial
membrane. Mitochondrial pyknosis has been sporadically
reported in the literature (30, 69, 100, 101, 114). The term
was first employed by Wachstein and Besen in a study of
renal tubular coagulative necrosis due to dl-serine intoxi-
cation in rats (124). It is interesting to observe that in this
paper, published before the first paper on apoptosis by
Kerr et al. (53), early focal lesions were identified in whichMancini et al. Mitochondrial Abnormalities and Apoptosis 465
isolated cells showed cytoplasmic condensation, nuclear
shrinkage with serrated irregular outlines, and preservation
of cellular membranes, aspects now recognized as “apoptotic.”
The appearance of mitochondrial pyknosis is associated
with activity in Colo-205 cell lysates after herbimycin ex-
posure and could therefore represent the morphological
correlative of the “point of no return” during the apop-
totic pathway. An example of apoptotic mitochondrial
morphology resembling mitochondrial pyknosis was re-
ported in cardiac sinus node myocytes in patients with
long QT syndrome and defined as “pleomorphic micromi-
tochondriosis” (48). In this study, mitochondrial pyknosis
was also associated with mitochondrial proliferation.
Cupler et al. reported mitochondrial proliferation and ul-
trastructural abnormalities similar to mitochondrial pyk-
nosis to be the earliest detectable lesion in zivudine (AZT)-
associated myopathy in HIV-infected patients (19). These
mitochondrial abnormalities could be one of the mecha-
nisms leading to muscular atrophy, characteristic of more
advanced stages of AZT-associated myopathy, through
apoptosis. A recent study by Reipert et al. also described
mitochondrial proliferation as an early response to treat-
ment of the hematopoietic stem cell line FDCP mix with
the topoisomerase II inhibitor etoposide, which induced
G2 arrest and apoptosis (95). The increase in mitochon-
drial mass in this model was not associated with mitochon-
drial pyknosis. The fact that in this study the mitochondria
became targets for autolytic digestion suggests however
that they may be defective.
Colo-205 cells showed increased ROS production after
herbimycin treatment. This response was preceded by mi-
tochondrial proliferation and loss of net mitochondrial
transmembrane potential and peaked at 96 h along with
maximal induction of apoptosis.
This sequence suggests a possible role of ROS as media-
tors of the apoptotic response to herbimycin. Mitochon-
dria could be a main target of nonspecific damage through
oxidative stress at the level of the outer and inner mem-
branes (12, 44). This mechanism has been described for
the elimination of mitochondria during the physiologic
maturation of reticulocytes into erythrocytes, which do not
contain mitochondria. Reticulocytes eliminate these or-
ganelles through the glycoprotein lipooxygenase, which
causes a disruption of both mitochondrial membranes by
oxidation of phospholipids in the outer and inner mem-
branes (92, 105). As a consequence of oxidative mem-
brane damage, membrane potential and permeability-bar-
rier function are impaired, leading to further mitochondrial
damage. Recently, oxidative damage to the mitochondrial
membrane due to increased generation of ROS has been
shown to play a role in apoptosis of thymocytes and bone
marrow cells in a murine model of Down’s syndrome (86).
Similar ROS-mediated mitochondrial membrane damage
has been detected as a possible cause of apoptosis in
Down’s syndrome human fetal cortical neurons (11). Mi-
tochondria have also been implicated as a source of ROS
during apoptosis. Reduced mitochondrial membrane po-
tential has recently been shown to lead to increased gener-
ation of ROS and apoptosis in dexamethasone-primed
murine splenocytes in vivo (127). Mitochondria are the
main source of cellular ROS (9, 117).
Mitochondrial dysfunction could also be more specifi-
cally programmed or targeted. There is precedent for the
activation or upregulation of specific agents of mitochon-
drial dysfunction in the mitochondrial uncoupling protein
present in brown fat adipocytes (80). This protein is a
membranous proton carrier that induces uncoupling of
mitochondrial respiration from ATP production by intro-
ducing a proton-conducting pathway through the mito-
chondrial inner membrane, with consequent decrease in
mitochondrial transmembrane potential, reduced ATP phos-
phorylation, and dissipation of energy as heat (96). The ac-
tivity of a mitochondrial uncoupler could be particularly
effective when its activation is linked to mitochondrial
proliferation, with consequent accumulation of dysfunc-
tional mitochondria and massive production of ROS. In
agreement with this hypothesis, NAC, a compound previ-
ously shown to protect cells against damage associated
with oxidative stress (3, 73, 74, 113) protected Colo-205
cells from herbimycin-induced apoptosis, without affecting
herbimycin-induced differentiation. However, mitochon-
drial proliferation and pyknosis in response to herbimycin
were also abolished by cotreatment with NAC, underlin-
ing the importance of unbalanced mitochondrial prolifera-
tion and dysfunction in the apoptotic response in Colo-205
cells. This unexpected result appears to provide evidence
for a redox-sensitive factor that governs the mitochondrial
proliferation response.
Another targeted mechanism for diminished mitochon-
drial function might involve the opening of the mitochon-
drial permeability transition pores (7, 46, 129). Mitochondrial
permeability transition has been recently proposed as a
critical early event in the apoptotic process (57, 70, 128).
It is also possible that mitochondria in herbimycin-
treated Colo-205 cells are defective at a biosynthetic level.
An example of this mechanism is the mitochondrial abnor-
malities, mentioned above, in the zivudine (AZT)-induced
myopathy in HIV-positive patients (19). Zivudine induces
inhibition of the mitochondrial DNA polymerase g, with
consequent mitochondrial DNA depletion, reduced syn-
thesis of mitochondrial subunits, and mitochondrial dys-
function (2, 75, 110). Mitochondrial proliferation may
function as a compensatory response (4) that, because of
the biosynthetic defect, is not sufficient to restore an ade-
quate mitochondrial function and leads to an accumulation
of dysfunctional mitochondria (19). Another experimental
model showing the deleterious effect of interference with
mitochondrial biosynthesis was reported by Garden et al.
(31). Neurons of the neonatal chick cochlear nucleus un-
dergo cell death after afferent deprivation via removal of
the cochlea, preceded by increased oxidative metabolism
and mitochondrial mass (47, 102). Inhibition of mitochon-
drial protein synthesis, by in vivo administration of chloram-
phenicol,  increases cell death after deafferentation (31).
Vayssiere et al. have also shown that reduction in DCm
during apoptosis can be associated with reduction in mito-
chondrial translation (123).
Cell-free assays for apoptosis enable testing of the con-
tribution of individual subcellular components or frac-
tions, exceeding the experimental possibilities using intact
cells (62). In addition, the temporal dependence of apop-
tosis on specific components can be examined (25, 54, 65,
71, 79). Our results show that subcellular fractions en-
riched in mitochondria are required for the apoptotic ac-The Journal of Cell Biology, Volume 138, 1997 466
tivity of lysates from Colo-205 cells treated for 24 h with
herbimycin. At later time points, latent apoptotic factors
in the cytosol are activated, and a strong mitochondrial de-
pendence is no longer observed. Therefore, the apoptotic
program induced by herbimycin requires the early action
of mitochondria. Previous studies have shown a require-
ment for mitochondria in cell-free assays of apoptosis us-
ing extracts from Xenopus oocytes (79) or hepatocytes or
lymphoid cells triggered to undergo apoptosis (128).
We also found evidence for the early timing of mito-
chondrial changes in herbimycin-induced apoptosis by ex-
amining their relationship to PARP cleavage. Cleavage of
PARP, a proteolytic target of the CPP32/Yama protease
(81, 115), has been described as an early event in drug-
induced and other models of apoptosis in mammalian cells
(25, 29, 51, 63, 106). Our results indicate that morphologi-
cal and functional mitochondrial changes, as well as in-
crease in ROS production, occur before detectable PARP
cleavage. A similar result was reported in a recent study of
cell death induced by respiratory chain inhibitors, etopo-
side or calcium ionophore (109).
An important aspect to consider in defining the role of
mitochondria in the process of apoptosis is the anti-apop-
totic proto-oncogene bcl-2, which encodes a protein localized
in the outer mitochondrial membrane as well as endoplas-
mic reticulum and nuclear membrane (56, 97). Over-
expression of Bcl-2 has been previously shown to suppress
lipid peroxidation and ROS generation as well as prevent
mitochondrial uncoupling (44, 50, 127). The Bcl-2 localiza-
tion studies suggest that Bcl-2 may function directly at the
mitochondrial membranes in these effects (42). Bcl-2 is
not detectable in Colo-205 cells by Western blot (Mancini,
M., and B. Anderson, unpublished result), but other mem-
bers of this family may function as survival factors in Colo-
205 cells. In addition to decreased expression or inhibitory
posttranslational modifications, the protective effect of
Bcl-2–like proteins could be diluted out by increased mito-
chondrial mass. Alternatively, Bcl-2 function might be re-
stricted to specific mitochondrial subsets.
Finally, the relationship between mitochondrial prolifer-
ation and cell cycle arrest may be important. Mitochon-
drial proliferation is associated with cell cycle arrest in G2/M
in Colo-205 cells after herbimycin treatment. Cell cycle ar-
rests in Saccharomyces cerevisiae and Schizosaccharomy-
ces pombe are associated with continued mitochondrial
replication, eventually leading to abnormal mitochondrial
morphologies (78, 104). Mitochondrial proliferation may
be a manifestation of continued cell growth dissociated
from cell cycle regulation (58). Dissociation between cyto-
plasmic and nuclear cell cycle events has been described in
CHO cells after treatment with multiple cytostatic agents
(59). In this model, a linear relationship between increased
cellular size after exposure to the drug and decreased via-
bility has been shown. G2 may be a sensitive phase of the
cell cycle for dissociation of cytoplasmic and nuclear
events in Colo-205 cells.
In conclusion, herbimycin A induces a proliferation of
dysfunctional mitochondria together with enterocytic dif-
ferentiation in Colo-205 cells. These mitochondrial changes
are preceded by cell cycle arrest and followed by apopto-
sis. The association of cell cycle arrest, mitochondrial ab-
normalities, and apoptosis may be a useful model to ex-
plain the linkage of terminal differentiation to apoptosis in
numerous cell lineages.
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